Published in FASEB J on May 01, 1998
The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch (2008) 1.72
L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circ Res (2009) 1.62
Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovasc Res (2010) 1.57
Substrate rigidity regulates Ca2+ oscillation via RhoA pathway in stem cells. J Cell Physiol (2009) 1.21
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci U S A (2006) 1.14
Mobilization of Ca2+ by cyclic ADP-ribose from the endoplasmic reticulum of cauliflower florets. Plant Physiol (2001) 1.11
The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem (2009) 1.06
MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J Biol Chem (2012) 1.04
SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells. J Mol Cell Cardiol (2010) 0.95
In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries. Exp Brain Res (2012) 0.94
Deletion of Dicer in smooth muscle affects voiding pattern and reduces detrusor contractility and neuroeffector transmission. PLoS One (2012) 0.92
Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers. Int J Cardiol (2009) 0.91
MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells. Biochem J (2012) 0.91
SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery. Gene Ther (2012) 0.87
Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels. Pflugers Arch (2014) 0.85
Mutation of delta-sarcoglycan is associated with Ca(2+) -dependent vascular remodeling in the Syrian hamster. Am J Pathol (2007) 0.84
Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells. Br J Pharmacol (2005) 0.84
Fluvastatin upregulates the α 1C subunit of CaV1.2 channel expression in vascular smooth muscle cells via RhoA and ERK/p38 MAPK pathways. Dis Markers (2014) 0.80
Cell culture retains contractile phenotype but epigenetically modulates cell-signaling proteins of excitation-contraction coupling in colon smooth muscle cells. Am J Physiol Gastrointest Liver Physiol (2012) 0.80
Mechanotransduction through fibronectin-integrin focal adhesion in microvascular smooth muscle cells: is calcium essential? Am J Physiol Heart Circ Physiol (2012) 0.79
The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells. PLoS One (2013) 0.77
Bladder smooth muscle organ culture preparation maintains the contractile phenotype. Am J Physiol Renal Physiol (2012) 0.77
An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem Cell Biol (2015) 0.76
Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca(2+) Channels Does Not Involve Ca(2+) Sensitization or Caldesmon. Front Pharmacol (2016) 0.75
Effects of Hyperglycemia on Vascular Smooth Muscle Ca(2+) Signaling. Biomed Res Int (2017) 0.75
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature (1999) 3.81
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother (1976) 2.98
Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis (1974) 2.93
Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res (2000) 2.76
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension (1986) 2.51
Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol Cell Biol (1999) 2.27
Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26
Infiltrates in protocol biopsies from renal allografts. Am J Transplant (2007) 2.24
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22
Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22
Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals (2002) 2.21
Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15
Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) (2008) 2.11
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (2000) 2.06
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension (2001) 2.04
Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein family. FEBS Lett (1997) 2.03
Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant (1996) 2.01
Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med (2001) 2.00
Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res (2001) 1.88
Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med (1998) 1.86
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis (1995) 1.85
Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83
Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72
Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res (2000) 1.71
Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol (2000) 1.69
Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun (1992) 1.66
Overnight urine collections to estimate sodium intake. Hypertension (1983) 1.58
Twin zygosity. Automated determination with microsatellites. J Reprod Med (1997) 1.53
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51
Mechanical stimulation of individual stereocilia of living cochlear hair cells by atomic force microscopy. Ultramicroscopy (2000) 1.50
Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn (1998) 1.50
Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis (1992) 1.49
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure. Eur J Clin Invest (2003) 1.49
Time for action. Arch Intern Med (1991) 1.48
Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy. J Mol Med (Berl) (1999) 1.48
Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J (1998) 1.48
Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother (1976) 1.45
Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45
A region on chromosome 3 is linked to dizygotic twinning. Nat Genet (2000) 1.44
Right-sided chest pain at the onset of haemodialysis. Nephrol Dial Transplant (2001) 1.44
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
The tell-tale urinary chloride. Nephrol Dial Transplant (2001) 1.39
Kidneys from pediatric donors: risk versus benefit. Clin Nephrol (1994) 1.39
STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant (2000) 1.38
Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38
A left-to-left shunt. Am J Med (1999) 1.38
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36
Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant (2011) 1.36
Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35
A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35
Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res (1996) 1.34
Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34
Hypertension-induced end-organ damage : A new transgenic approach to an old problem. Hypertension (1999) 1.32
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension (1999) 1.30
Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol (2001) 1.29
Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. Soc Sci Med (1995) 1.29
Beta subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem (1997) 1.27
Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int (2006) 1.23
Trauma involving the proximal tibial epiphysis. Arch Orthop Trauma Surg (1991) 1.23
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci (2000) 1.23
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet (1996) 1.22
From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J (1997) 1.21
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study. Int J Clin Pract (2011) 1.20
Skin decontamination by low-temperature atmospheric pressure plasma jet and dielectric barrier discharge plasma. J Hosp Infect (2012) 1.19
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension (2001) 1.19
Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant (1999) 1.19
Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension (1983) 1.19
QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation (1999) 1.18
Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure. Antimicrob Agents Chemother (1977) 1.18
Minoxidil treatment of malignant hypertension. Recovery of renal function. JAMA (1978) 1.17
Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res (1998) 1.17